Sector report: oncology

Cancer is a leading cause of mortality worldwide, accounting for nearly 10 million deaths in 2020. What is less well known is if medical research could reduce cancer mortality by just 10% it would be worth $5 trillion in the US alone.

The net gain would be especially large if we could reduce cancer mortality with new drugs, which are typically cheap to make once discovered. “A reduction in cancer mortality of this size does not seem beyond reach and…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
James Mawson

James Mawson is founder and chief executive of Global Venturing.